GSE126463 pomalidomide MM1.S 6 v 2 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE126463_pomalidomide_MM1.S_6_v_2_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE126463_pomalidomide_MM1.S_6_v_2_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE126463_pomalidomide_MM1.S_6_v_2_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE126463_pomalidomide_MM1.S_6_v_2_human_up.

Results found

Linked to

 

Label

Description

 

Gene

small nucleolar RNA host gene 3

Gene

Pvt1 oncogene

Gene

multidrug resistance-related protein

Gene

MIR34A host gene

Gene

long intergenic non-protein coding RNA 887

Gene

ankyrin repeat domain 36B pseudogene 2

Gene

long intergenic non-protein coding RNA 1451

Gene

ovostatin 2, pseudogene

Gene

coiled-coil domain containing 144C, pseudogene

Gene

uncharacterized LOC105375517

  • Gene

    small nucleolar RNA host gene 3



  • Gene

    multidrug resistance-related protein



  • Gene

    long intergenic non-protein coding RNA 887


  • Gene

    ankyrin repeat domain 36B pseudogene 2


  • Gene

    long intergenic non-protein coding RNA 1451


  • Gene

    ovostatin 2, pseudogene


  • Gene

    coiled-coil domain containing 144C, pseudogene


  • Gene

    uncharacterized LOC105375517

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.